Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
Not Applicable
Not yet recruiting
- Conditions
- Lymphoblastic Leukemia
- Registration Number
- NCT06746571
- Lead Sponsor
- Sohag University
- Brief Summary
Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy
- Detailed Description
Role of neutrophil to lymph ratio , lymphocyte to monocyte ratio and platelet to lymphocyte in acute lymphoblastic leukemia adults and pediatric patients to explore the prognostic role of them in prediction the response to induction chemotherapy
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- patients newly diagnosed ALL
Exclusion Criteria
- others malignanices
- ALL on therapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method neutrophil to lymphocyte ratio 1 year count of neutophils comparing lymphocytees
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do neutrophil-to-lymphocyte ratios correlate with BCR-ABL1 mutations in ALL patients undergoing induction chemotherapy?
How effective are CBC indices compared to minimal residual disease testing in predicting ALL treatment response?
Which CBC-derived biomarkers best predict response to induction chemotherapy in pediatric vs. adult ALL?
What adverse events are associated with high platelet-to-lymphocyte ratios in ALL patients during chemotherapy?
How might NLR and LMR guide combination therapies with tyrosine kinase inhibitors in ALL?
Trial Locations
- Locations (1)
Sohag university Hospital
🇪🇬Sohag, Egypt